Icneta 200 Capsule contains Itraconazole 200 mg, a broad-spectrum triazole antifungal agent used for the treatment of various fungal infections. Itraconazole works by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting membrane integrity and leading to fungal cell death. Icneta 200 is indicated for the management of systemic and superficial mycoses, including aspergillosis, blastomycosis, histoplasmosis, onychomycosis, and candidiasis. The capsule formulation ensures optimal bioavailability and convenient oral administration. Icneta 200 should be taken with food to enhance absorption. Dosage and duration of therapy depend on the type and severity of infection, and treatment should be guided by clinical response and laboratory findings. Caution is advised in patients with hepatic impairment, as itraconazole is metabolized primarily by the liver. Potential adverse effects include gastrointestinal disturbances, headache, rash, and elevated liver enzymes. Icneta 200 may interact with other drugs metabolized via the cytochrome P450 system, necessitating careful monitoring and dose adjustments. It is contraindicated in patients with known hypersensitivity to itraconazole and in those with congestive heart failure. Regular monitoring of liver function and clinical status is recommended during therapy to ensure safety and efficacy.

Dosage & How to Use